Publications by authors named "Julia B Bailey"
J Affect Disord
November 2023
Article Synopsis
- * Zuranolone (SAGE-217) is a new oral treatment that enhances GABA signaling and has shown rapid, meaningful antidepressant effects in multiple studies involving 1,662 participants with MDD.
- * Zuranolone has a good safety profile, with minimal serious side effects, and is FDA-approved for postpartum depression; future research will focus on its long-term effectiveness and applicability to other forms of depression.
